生物标志物用于诊断溃疡性结肠炎或评估其活动性的研究进展
Research Progress in the Study of Biomarkers for Diagnosing Ulcerative Colitis or Assessing Its Activity
DOI: 10.12677/ACM.2024.141169, PDF,   
作者: 杨 琳：新疆医科大学第四临床医学院，新疆 乌鲁木齐；苏莎莎*：新疆医科大学附属中医医院，新疆 乌鲁木齐
关键词: 生物标志物；诊断；评估；溃疡性结肠炎；活动性；研究进展；Biomarkers； Diagnosis； Assessment； Ulcerative Colitis； Activity； Research Progress
摘要: 溃疡性结肠炎(UC)是常见的炎症性肠病，目前UC的全球发病率日益升高，而内窥镜、病理组织学检查无法满足短期内反复筛查和动态监测病情变化的需要，需要有效利用粪便标志物和血清标志物。为此，本文概述了生物标志物与溃疡性结肠炎，分析了生物标志物诊断溃疡性结肠炎或评估其活动性的研究进展，指出了生物标志物诊断溃疡性结肠炎的价值，最后总结和展望相关研究，旨在为临床诊断和治疗提供参考思路。
Abstract: Ulcerative colitis (UC) is a common inflammatory bowel disease, and nowadays the global incidence of UC is increasing, and endoscopy and pathohistology cannot meet the need for repeated screening and dynamic monitoring of the disease changes in a short period of time, so there is a need for effec-tive use of fecal markers and serum markers. To this end, this article provides an overview of bi-omarkers and ulcerative colitis, analyzes the research progress of biomarkers in diagnosing ulcera-tive colitis or evaluating its activity, points out the value of biomarkers in diagnosing ulcerative co-litis, and finally summarizes and looks forward to related studies, aiming to provide reference ideas for clinical diagnosis and treatment.
文章引用：杨琳, 苏莎莎. 生物标志物用于诊断溃疡性结肠炎或评估其活动性的研究进展[J]. 临床医学进展, 2024, 14(1): 1167-1172. https://doi.org/10.12677/ACM.2024.141169

参考文献

[1] 张宪波, 刘月皎, 陈云峰. 粪便钙卫蛋白在肠易激综合征和炎症性肠病鉴别诊断中的意义分析[J]. 现代检验医学杂志, 2021, 36(1): 124-127.
[2] Yagi, S., Furukawa, S., Shiraishi, K., et al. (2021) Effect of Disease Duration on the Association between Serum Albumin and Mucosal Healing in Patients with Ulcerative Colitis. BMJ Open Gastroen-terology, 8, e000662. [Google Scholar] [CrossRef] [PubMed]
[3] 张怡婷, 钱香, 任真, 等. 粪便钙卫蛋白联合血液指标在诊断及评估溃疡性结肠炎活动度中的临床价值[J]. 实用医学杂志, 2021, 37(9): 1199-1202.
[4] 宁萌, 孙妍, 郑长清, 等. 上海市嘉定区炎症性肠病患者的粪便钙卫蛋白检测研究[J]. 中华消化病与影像杂志, 2021, 11(5): 193-195.
[5] 安玉秋, 王惠娟. 溃疡性结肠炎中医证型分布及与肠镜象相关性研究进展[J]. 中国中西医结合消化杂志, 2021, 29(5): 373-376.
[6] Maaser, C., Petersen, F., Helwig, U., et al. (2020) lntestinal Ultra-Sound for Moni-toring Therapeutic Response in Patients with Ulcerative Colitis: Results from the TRUST&UC Study. Gut, 69, 1629-1636. [Google Scholar] [CrossRef] [PubMed]
[7] 陈金敏, 高山, 童旭东. 非侵人性分子标志物对溃疡性结肠炎内镜活动度的判断价值[J]. 胃肠病学, 2019, 24(5): 298-301.
[8] 林美英, 黄江山, 唐熟能. 溃疡性结肠炎患者粪便中FCP及CRP水平与病情程度的相关性[J]. 医学理论与实践, 2021, 34(20): 3619-3621.
[9] 韩牧洲, 朱思莹, 施海韵, 等. 粪便钙卫蛋白联合粪便免疫化学试验在溃疡性结肠炎患者黏膜愈合中的诊断价值[J]. 现代消化及介人诊疗, 2022, 27(3): 297-301.
[10] Hart, L., Chavannes, M., Kherad, O., et al. (2020) Faecal Calprotectin Predicts Endoscopic and Histological Activity in Clinically Quiescent Ulcerative Colitis. Journal of Crohn’s and Colitis, l4, 46-52. [Google Scholar] [CrossRef] [PubMed]
[11] Kanmat, N., Vuyyuru, S.K., Kedia, S., et al. (2022) Correlation of Fecal Calprotectin and Patient-Reported Outcome Measures in Patients with Ulcerative Colitis. Intestinal Research, 20, 269-273. [Google Scholar] [CrossRef] [PubMed]
[12] Ishida, N., Tani, S., Asai, Y., et al. (2022) Lymphocyte to Monocyte Ratio and Serum Albumin Changes Predict Tacrolimus Therapy Outcomes in Patients with Ulcerative Colitis. Scientific Reports, 12, Article No. 13572. [Google Scholar] [CrossRef] [PubMed]
[13] Jain, S., Kedia, S., Bopanna, S., et al. (2017) Faecal Calprotectin and UCEIS Predict Short-Term Outcomes in Acute Severe Colitis: Prospective Cohort Study. Journal of Crohn’s and Colitis, 11, 1309-1316. [Google Scholar] [CrossRef] [PubMed]
[14] 贾勤, 董争华, 赵晓明. 粪便钙卫蛋白与肠镜检查对溃疡性结肠炎诊断及分型的意义分析[J]. 临床血液学杂志, 2023, 36(6): 417-422.
[15] 王晚彤. 粪便钙卫蛋白联合血清标志物在评估溃疡性结肠炎活动性中的作用[D]: [硕士学位论文]. 大连: 大连医科大学, 2021.
[16] Walsh, A., Kormilitzin, A., Hinds, C., et al. (2019) Defining Faecal Calprotectin Thresholds as a Surrogate for Endoscopic and His-tological Disease Activity in Ulcerative Colitis a Prospective Analysis. Journal of Crohn’s and Colitis, 13, 424-430. [Google Scholar] [CrossRef] [PubMed]
[17] 金健威, 卢光荣, 宋丽, 等. 粪便钙卫蛋白在溃疡性结肠炎活动性及病变严重程度评估中的应用价值[J]. 重庆医学, 2020, 49(7): 1140-1144.
[18] Borkowska, A., Liberek, A., Luczak, G., et al. (2015) Fecal Lactoferrin, a Marker of Intestinal Inflammation in Children with Inflammatory Bowel Disease. Acta Biochimica Polonica, 62, 541-545. [Google Scholar] [CrossRef] [PubMed]
[19] Sorrentino, D. and Gray, J.M. (2021) Timely Monitoring of Inflammation by Fecal Lactoferrin Rapidly Predicts Therapeutic Response in In-flammatory Bowel Disease. Inflammatory Bowel Diseases, 27, 1237-1247. [Google Scholar] [CrossRef] [PubMed]
[20] Lakatos, G., Sipos, F., Miheller, P., et al. (2012) The Behavior of Matrix Metalloproteinase-9 in Lymphocytic Colitis, Collagenous Colitis and Ulcerative Colitis. Pathology & Oncology Research, 18, 85-91. [Google Scholar] [CrossRef] [PubMed]
[21] 陈伦虎, 宋方敏, 李和平, 等. 粪便钙卫蛋白联合血清降钙素原、C反应蛋白在评估溃疡性结肠炎病情严重程度中的价值[J]. 吉林医学, 2020, 41(10): 2340-2341.
[22] 韩娟, 华文龙. 炎症标志物对溃疡性结肠炎临床价值比较[J]. 临床血液学杂志, 2021, 34(6): 390-393.
[23] 牛丽娜, 李艳梅, 刘小方. 粪便钙卫蛋白、降钙素原在溃疡性结肠炎及腹泻型肠易激综合征诊断中的临床意义[J]. 现代消化及介人诊疗, 2018, 23(6): 742-747.
[24] 何琼, 李建栋. 炎症性肠病流行病学研究进展[J]. 实用医学杂志, 2019, 35(18): 2962-2966.
[25] 赵尚飞, 姜娜, 宋明全. 粪钙卫蛋白、血小板、D-二聚体及降钙素原与溃疡性结肠炎的相关性分析[J]. 中国中西医结合消化杂志, 2021, 29(6): 431-435.
[26] 高丹, 王科峰, 卢丽萍. 粪便钙卫蛋白联合血清学抗体检测诊断炎症性肠病的临床应用价值[J]. 中国医科大学学报, 2021, 50(5): 425-428.
[27] Nowak, J.K., Kalla, R. and Satsangi, J. (2023) Current and Emerging Biomarkers for Ulcerative Colitis. Expert Review of Molecular Diagnostics, 23, 1107-1119. [Google Scholar] [CrossRef] [PubMed]
[28] Reghefaoui, M., Peresuodei, T.S., Saavedra Palacios, M.S., et al. (2023) The Role of Serological Markers in the Prediction of Disease Course and Response to Therapy in Inflammatory Bowel Disease. Cureus, 15, e48442. [Google Scholar] [CrossRef] [PubMed]
[29] Tatsumi, Y., Kakimoto, K., Hara, A., et al. (2023) Biomarkers for Mon-itoring of Changes in Disease Activity in Ulcerative Colitis. Journal of Clinical Medicine, 12, Article 7165. [Google Scholar] [CrossRef] [PubMed]

为你推荐